Taro Pharmaceutical Industries Ltd.
NYSE:TARO
Overview | Financials
Company Name | Taro Pharmaceutical Industries Ltd. |
Symbol | TARO |
Currency | USD |
Price | 42.975 |
Market Cap | 1,615,198,185 |
Dividend Yield | 0% |
52-week-range | 32.67 - 45.76 |
Industry | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Mr. Uday V. Baldota |
Website | https://www.taro.com |
An error occurred while fetching data.
About Taro Pharmaceutical Industries Ltd.
Taro Pharmaceutical Industries Ltd., a science-based pharmaceutical company, develops, manufactures, and markets prescription and over-the-counter pharmaceutical products in the United States, Canada, Israel, and internationally. The company also develops and manufactures active pharmaceutical ingredients primarily for use in its finished dosage form products. It offers its products for various therapeutic
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD